标题
Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 2, Pages 613
出版商
MDPI AG
发表日期
2020-01-17
DOI
10.3390/ijms21020613
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy
- (2018) Alessandra Romano et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance
- (2018) Sabrina Manni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
- (2018) Song Xu et al. LEUKEMIA
- Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
- (2018) Alice Santi et al. PROTEOMICS
- Pathogenesis of bone disease in multiple myeloma: from bench to bedside
- (2018) Evangelos Terpos et al. Blood Cancer Journal
- Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update
- (2018) Hanley Abramson INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes
- (2018) Maria Antonia Frassanito et al. JOURNAL OF PATHOLOGY
- Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression
- (2017) Jianan Pang et al. HAEMATOLOGICA
- Bone Niches, Hematopoietic Stem Cells, and Vessel Formation
- (2017) Roberto Tamma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
- (2017) Stefan B. Eichmüller et al. JNCI-Journal of the National Cancer Institute
- CAR T cell therapy for multiple myeloma: where are we now and where are we headed?
- (2017) Arnab Ghosh et al. LEUKEMIA & LYMPHOMA
- Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
- (2017) Caterina Musolino et al. MEDIATORS OF INFLAMMATION
- Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
- (2017) Fengming Yang et al. Molecular Cancer
- Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression
- (2017) Patrizia Mondello et al. Oncotarget
- Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation
- (2017) Federica Costa et al. Oncotarget
- Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line
- (2017) Diogo Gomes-Silva et al. Biotechnology Journal
- Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression
- (2017) Jianan Pang et al. HAEMATOLOGICA
- Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
- (2017) Stefan B. Eichmüller et al. JNCI-Journal of the National Cancer Institute
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism
- (2017) Jiwoo Lee et al. PLoS One
- The T Cell in Myeloma
- (2016) Douglas Joshua et al. Clinical Lymphoma Myeloma & Leukemia
- Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates With Progression of Human Myeloma
- (2016) Alberto L Horenstein et al. MOLECULAR MEDICINE
- Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy
- (2016) Wen Yu et al. Oncotarget
- Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies
- (2016) Antonia Reale et al. Stem Cells International
- Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells
- (2016) Carolyne Falank et al. Frontiers in Endocrinology
- Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing
- (2015) P. Leone et al. BLOOD
- CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon
- (2015) J. P. Laubach et al. CLINICAL CANCER RESEARCH
- Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients
- (2015) M A Frassanito et al. LEUKEMIA
- PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
- (2015) B Paiva et al. LEUKEMIA
- Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells
- (2015) A Ray et al. LEUKEMIA
- Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
- (2015) Lin Zhang et al. NATURE
- Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma
- (2015) Min Wang et al. Oncotarget
- Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation
- (2015) Zhiqiang Liu et al. Oncotarget
- The Analysis of the Relationship between Multiple Myeloma Cells and Their Microenvironment
- (2015) Artur Jurczyszyn et al. Journal of Cancer
- Bone-Immune Cell Crosstalk: Bone Diseases
- (2015) Giorgio Mori et al. Journal of Immunology Research
- Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival
- (2015) Giulia Di Lullo et al. OncoImmunology
- Cellular immunotherapy in multiple myeloma: Lessons from preclinical models
- (2014) M. Binsfeld et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Role of endothelial progenitor cells in cancer progression
- (2014) Michele Moschetta et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells
- (2014) J. Wang et al. BLOOD
- Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway
- (2014) Fu-Ming Zi et al. CANCER BIOLOGY & THERAPY
- A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target
- (2014) A. Ferrucci et al. CLINICAL CANCER RESEARCH
- HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment
- (2014) Enrica Borsi et al. EXPERIMENTAL CELL RESEARCH
- Targeting the bone marrow microenvironment in multiple myeloma
- (2014) Yawara Kawano et al. IMMUNOLOGICAL REVIEWS
- The Alteration and Clinical Significance of Th1/Th2/Th17/Treg Cells in Patients with Multiple Myeloma
- (2014) Ping Feng et al. INFLAMMATION
- Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
- (2014) Jesús F San-Miguel et al. LANCET ONCOLOGY
- Current treatment landscape for relapsed and/or refractory multiple myeloma
- (2014) Meletios A. Dimopoulos et al. Nature Reviews Clinical Oncology
- Prognostic relevance of cancer-associated fibroblasts in human cancer
- (2014) Janna Paulsson et al. SEMINARS IN CANCER BIOLOGY
- Microenvironment and multiple myeloma spread
- (2014) Domenico Ribatti et al. THROMBOSIS RESEARCH
- Plasticity of γδ T Cells: Impact on the Anti-Tumor Response
- (2014) Virginie Lafont et al. Frontiers in Immunology
- PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma
- (2013) P. G. Richardson et al. BLOOD
- HIF-1 of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
- (2013) R. Ria et al. CLINICAL CANCER RESEARCH
- Decreased Affinity of Recombinant Human Tumor Necrosis Factor-related Apoptosis-inducing Ligand (rhTRAIL) D269H/E195R to Osteoprotegerin (OPG) Overcomes TRAIL Resistance Mediated by the Bone Microenvironment
- (2013) Matthieu C. J. Bosman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies
- (2013) M A Frassanito et al. LEUKEMIA
- Adipocytic Cells Augment the Support of Primitive Hematopoietic Cells In Vitro But Have No Effect in the Bone Marrow Niche Under Homeostatic Conditions
- (2013) Tassja J. Spindler et al. STEM CELLS AND DEVELOPMENT
- A three-party alliance in solid tumors
- (2013) Marek Wagner et al. Adipocyte
- The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma
- (2012) Walter M. T. Braga et al. Clinical & Developmental Immunology
- Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry
- (2012) R. J. Pessoa de Magalhaes et al. HAEMATOLOGICA
- Bone Marrow Microenvironment in Multiple Myeloma Progression
- (2012) S. Manier et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
- (2012) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Tumour-Initiating Cells with TRAIL Based Combination Therapy Ensures Complete and Lasting Eradication of Multiple Myeloma Tumours In Vivo
- (2012) Srdjan Vitovski et al. PLoS One
- Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma
- (2012) Ross Brown et al. OncoImmunology
- Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion
- (2011) Yuan Zhang et al. CANCER LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions
- (2011) Yan Huang et al. CLINICAL & EXPERIMENTAL METASTASIS
- Multiple Myeloma Mesenchymal Stem Cells: Characterization, Origin, and Tumor-Promoting Effects
- (2011) M. R. Reagan et al. CLINICAL CANCER RESEARCH
- Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
- (2011) Mu Hao et al. LEUKEMIA & LYMPHOMA
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets
- (2011) S Berardi et al. ONCOGENE
- Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells
- (2010) S Colla et al. LEUKEMIA
- Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
- (2010) Stephanie Markovina et al. Molecular Cancer
- TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
- (2010) Kyoko Takeuchi et al. PLoS One
- Autocrine TGF- and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
- (2010) Y. Kojima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
- (2010) M. K. Brimnes et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-
- (2010) M. Kraman et al. SCIENCE
- Bortezomib induces osteoblast differentiation via Wnt-independent activation of -catenin/TCF signaling
- (2009) Y.-W. Qiang et al. BLOOD
- Targeting Angiogenesis via a c-Myc/Hypoxia-Inducible Factor-1 -Dependent Pathway in Multiple Myeloma
- (2009) J. Zhang et al. CANCER RESEARCH
- Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
- (2009) R. Ria et al. CLINICAL CANCER RESEARCH
- Cancer associated fibroblasts in cancer pathogenesis
- (2009) Omar E. Franco et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
- (2008) R. Ria et al. CLINICAL CANCER RESEARCH
- The role of microenvironment in tumor angiogenesis
- (2008) Domenico Ribatti et al. Genes and Nutrition
- Mast Cells Contribute to Vasculogenic Mimicry in Multiple Myeloma
- (2008) Beatrice Nico et al. STEM CELLS AND DEVELOPMENT
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started